Universitäres Centrum für Tumorerkrankungen Mainz (UCT Mainz)
Klinisch orientierter Schwerpunkt / Johannes Gutenberg-Universität Mainz
Alexa, Matthias; Hasenburg, Annette; Battista, Marco Johannes
The TCGA Molecular Classification of Endometrial Cancer and Its Possible Impact on Adjuvant Treatment DecisionsCANCERS. Bd. 13. H. 6. 2021
Rink, Andreas D.
Total neoadjuvant Therapy for Patients with Rectal Cancer A useful Concept for advanced TumorsCOLOPROCTOLOGY. Bd. 43. H. 3. 2021 S. 229-231
Schuler, Esther; Wagner-Drouet, Eva-Maria; Ajib, Salem et al.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group (vol 100, pg 959, 2021)ANNALS OF HEMATOLOGY. Bd. 100. H. 8. 2021 S. 2141-2142
Oosting, Sjoukje F.; Desideri, Isacco; Staelens, Dominiek et al.
Treatment patterns in older patients with locally advanced head and neck squamous cell carcinoma: Results from an EORTC led surveyJOURNAL OF GERIATRIC ONCOLOGY. Bd. 12. H. 8. 2021 S. 1261-1265
Rausch, Johanna; Windschmitt, Johannes; Schilling, Carolin et al.
Treatment-Induced Aggravation of Vasculitis in Hairy-Cell LeukemiaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA. Bd. 21. H. 5. 2021 S. E429-E431
van den Berg, M. H.; van Dijk, M.; Byrne, J. et al.
Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)HUMAN REPRODUCTION. Bd. 36. H. 6. 2021 S. 1561-1573
Llovet, Josep M.; Villanueva, Augusto; Marrero, Jorge A. et al.
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceHEPATOLOGY. Bd. 73. 2021 S. 158-191
Vogler, Meike; Shanmugalingam, Senthan; Sarchen, Vinzenz et al.
Unleashing the power of NK cells in anticancer immunotherapyJOURNAL OF MOLECULAR MEDICINE-JMM. Bd. 100. H. 3. 2021 S. 337-349
Heimes, Anne-Sophie; Schmidt, Marcus
Update on immuno-oncology in triple-negative breast cancerGYNAKOLOGE. Bd. 54. H. 8. 2021 S. 590-595
El-Khoueiry, Anthony B.; Kim, Richard D.; Harris, William Proctor et al.
Updated results of a phase 1b study of regorafenib (REG) 80 mg/day or 120 mg/day plus pembrolizumab (PEMBRO) for first-line treatment of advanced hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 15. 2021